Lipoprotein(a) in renal disease
- 31 January 1996
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (1), 1-25
- https://doi.org/10.1016/s0272-6386(96)90026-8
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Thyroid hormone (fT4) reduces lipoprotein(a) plasma levelsAtherosclerosis, 1995
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosisAtherosclerosis, 1994
- Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor‐related protein/α2‐macroglobulin receptorFEBS Letters, 1993
- Identification of 34 Apolipoprotein(a) Isoforms: Differential Expression of Apolipoprotein(a) Alleles between American Blacks and WhitesBiochemical and Biophysical Research Communications, 1993
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Lipoprotein a inhibits streptokinase-mediated activation of human plasminogenBiochemistry, 1989
- Reduction of lp(a) by different methods of plasma exchangeKlinische Wochenschrift, 1988
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- The Hyperlipidemia of the Nephrotic SyndromeNew England Journal of Medicine, 1985